Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals was founded in 1999 and is headquartered in Nashville, Tennessee. Cumberland Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.

Contact Details

Office Address

Cumberland Pharmaceuticals Inc.
2525 West End Avenue, Suite 950
Nashville, TN, USA 37203
Phone: (615) 255-0068
Fax: (615) 255-0094


Founder, Chairman, Chief Exec. Officer and Pres.

Mr. A. J. Kazimi

Chief Financial Officer

Mr. David L. Lowrance

Business Reviews for Cumberland Pharmaceuticals Inc.

Related Companies